SCHEMBL23733836

SCHEMBL23733836

Fc1cccc(-c2nc(-c3ccc(-c4ccc(-c5ccc(-c6ccc7ccccc7c6)cc5)cc4)cc3)nc(-c3cccc(F)c3)n2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.53
ESR2 Q92731 2/20 0.49
HSD17B1 P14061 1/20 0.47
HSD17B2 P37059 1/20 0.47
CYP1A2 P05177 2/20 0.47
CYP2A6 P11509 1/20 0.47
ESR1 P03372 1/20 0.46
PDGFRB P09619 1/20 0.46
PDGFRA P16234 1/20 0.46
KDM4E B2RXH2 1/20 0.45
MEN1 O00255 1/20 0.45
ALDH1A1 P00352 1/20 0.45
TP53 P04637 1/20 0.45
KMT2A Q03164 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HSD17B10 Q99714 1/20 0.45
CYP17A1 P05093 2/20 0.45
CYP11B1 P15538 2/20 0.45
CYP11B2 P19099 2/20 0.45
CYP19A1 P11511 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23733826 0.88 HSD17B1 (0.49) TAAR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL23733872 0.88 HSD17B1 (0.49) TAAR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL23733783 0.88 HSD17B1 (0.49) ESR2HSD17B1HSD17B2CYP1A2CYP2A6
SCHEMBL23733839 0.88 TAAR1 (0.57) TAAR1ESR2MEN1ALDH1A1TP53
SCHEMBL28880094 0.88 TAAR1 (0.57) TAAR1ESR2MEN1ALDH1A1TP53
SCHEMBL14426037 0.88 HSD17B1 (0.55) ESR2HSD17B1HSD17B2CYP1A2ESR1
SCHEMBL23733840 0.88 TAAR1 (0.57) TAAR1ESR2MEN1ALDH1A1TP53
SCHEMBL23733871 0.88 TAAR1 (0.62) TAAR1ESR2MEN1ALDH1A1KMT2A
SCHEMBL3368772 0.88 CYP1A2 (0.60) TAAR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL24353259 0.86 MEN1 (0.54) ESR2HSD17B1HSD17B2CYP1A2ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11844273-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-12-12 US disclosed
US-11844273-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-12-12 US disclosed
US-11563183-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-01-24 US disclosed
US-20210367158-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-11-25 US disclosed
US-11088331-B2 2021-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11563183-B2 Heterocyclic compound and organic light-emitting device including the same DDT, PPOX, LEF1 TAAR1 3612/4885ESR2 1573/4885HSD17B1 827/4885
US-11844273-B2 Heterocyclic compound and organic light-emitting device including the same DDT, PPOX, LEF1 TAAR1 3612/4885ESR2 1573/4885HSD17B1 827/4885
US-11088331-B2 DDT, PPOX, DBF4 TAAR1 3540/4885ESR2 1438/4885HSD17B1 1099/4885
US-20210367158-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME DDT, PPOX, LEF1 TAAR1 3612/4885ESR2 1573/4885HSD17B1 827/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.